Abstract
The purpose of this article is to provide scientific evidence on mood stabilizers used in the treatment of bipolar disorder. Indeed, it has proven difficult to develop drugs for this disorder, particularly in long-term treatment for relapse prevention. We review the main drugs that have obtained approval for use in the European Union and the United States. We take again the clinical studies which provided the basis for the evaluations. These studies are few in number and relatively old as it is difficult to conduct them in bipolar disorder. These are studies in monotherapy but also in dual therapy which better reflects the daily use of these drugs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
